Trivium Point Advisory LLC Acquires New Position in CME Group Inc. $CME

Trivium Point Advisory LLC acquired a new position in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 5,100 shares of the financial services provider’s stock, valued at approximately $1,126,000.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in CME Group by 1.7% during the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after purchasing an additional 588,509 shares during the period. State Street Corp increased its position in CME Group by 0.4% in the fourth quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock worth $4,408,747,000 after buying an additional 56,725 shares during the period. Norges Bank bought a new stake in CME Group in the fourth quarter valued at $1,523,241,000. Bank of New York Mellon Corp lifted its stake in CME Group by 2.8% in the fourth quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock valued at $1,344,776,000 after buying an additional 134,242 shares during the last quarter. Finally, Raymond James Financial Inc. boosted its holdings in shares of CME Group by 5.4% during the fourth quarter. Raymond James Financial Inc. now owns 4,319,763 shares of the financial services provider’s stock valued at $1,179,858,000 after acquiring an additional 222,890 shares during the period. Institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

CME has been the subject of several recent research reports. Wall Street Zen lowered shares of CME Group from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 1st. Piper Sandler reduced their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating for the company in a research note on Wednesday, July 15th. Barclays decreased their target price on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research report on Thursday, July 9th. UBS Group cut their price target on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. Finally, TD Cowen reduced their price objective on CME Group from $323.00 to $273.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Ten investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $291.81.

CME Group Price Performance

Shares of NASDAQ CME opened at $269.80 on Monday. The stock has a market cap of $97.01 billion, a P/E ratio of 22.88, a P/E/G ratio of 3.14 and a beta of 0.23. The firm’s 50-day simple moving average is $250.20 and its 200 day simple moving average is $280.19. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. CME Group’s revenue was up .8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.96 EPS. Equities analysts expect that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio is currently 44.11%.

Insider Activity

In related news, Director William R. Shepard acquired 325 shares of the firm’s stock in a transaction dated Thursday, June 25th. The stock was acquired at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director directly owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.